Related Experiment Video
Updated: Jul 1, 2025
03:23
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
749
Eosinophilic Asthma: Pathophysiology and Therapeutic Horizons
Musaddique Hussain1, Gang Liu1
1Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Cells
|March 13, 2024
Summary
Targeting eosinophils in severe asthma shows promise for reducing airway remodeling and disease progression. Understanding eosinophilic asthma phenotypes, endotypes, and biomarkers is key to developing effective targeted therapies.
Area of Science:
- Immunology
- Pulmonology
- Pharmacology
Background:
- Asthma affects 300 million globally, characterized by airway inflammation and remodeling.
- Eosinophilic asthma involves eosinophil accumulation, releasing mediators that worsen inflammation and damage.
- Targeting eosinophils may mitigate airway remodeling and slow asthma progression.
Purpose of the Study:
- To review the role of eosinophils in severe asthma.
- To explore eosinophilic asthma phenotypes, endotypes, and biomarkers.
- To examine current and emerging biologic agents targeting eosinophils.
Main Methods:
- Literature review of immunopathology, biomarkers, and targeted therapies for eosinophilic asthma.
- Analysis of phenotypes and endotypes contributing to severe asthma.
- Evaluation of biological agents targeting eosinophil-driven inflammation.
Main Results:
- Eosinophils significantly contribute to severe asthma inflammation and tissue damage.
- Accurate patient categorization by phenotype and endotype is crucial.
- Various biomarkers are associated with eosinophilic asthma pathology.
Conclusions:
- Understanding eosinophil immunopathology is vital for severe asthma management.
- Targeted therapies focusing on eosinophils offer potential for improved treatment outcomes.
- Further research into eosinophil-specific biomarkers and therapies is warranted.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
396
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
396
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
294
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
294
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:19Antiasthma Drugs: Leukotriene Modifiers
297
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
297
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K